Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harold Jacob Insider Profile
4 Followers
Harold Jacob, Director at Oramed Pharm, holds 25.60K shares in Oramed Pharm (Ticker: ORMP), holds ― shares in NanoVibronix (Ticker: NAOV). Most recently, Harold Jacob Sold ― shares of Oramed Pharm on Mar 14, 2016 for an estimated value of 54.83K.
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+10.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Harold Jacob holds in companies
Most Profitable Insider Trade
The most profitable trade made by Harold Jacob
Harold Jacob's Trading History
Oramed Pharm
Mar 14, 2016
Director
Informative Sell
54.83K
$65.27K
NanoVibronix
―
CMO, Director
―
―
List of latest transactions for each holding click on a transaction to see Harold Jacob's performance on stock
You May Also Like
Harold Jacob insider profile FAQ
What is the percentage of profitable transactions made by Harold Jacob?
The percentage of profitable transactions made by Harold Jacob is 67%.
What is the average return per transaction made by Harold Jacob?
The average return per transaction made by Harold Jacob is 10.70%.
What stocks does Harold Jacob hold?
Harold Jacob holds: ORMP, NAOV stocks.
What was Harold Jacob’s latest transaction?
Harold Jacob latest transaction was an Informative Sell of $54.83K.
What was Harold Jacob's most profitable transaction?
Harold Jacob’s most profitable transaction was an Informative Sell of ORMP stock on January 29, 2014. The return on the trade was 53.10%.
What is Harold Jacob's role in Oramed Pharm?
Harold Jacob's role in Oramed Pharm is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.